Additionally, our matching process, which took into account factors such as age, sex, lupus activity parameters (anti-dsDNA IgG titers and C3 levels), and organ damage (chronic kidney disease), helped mitigate the risk of selection bias. The gene discussed is C3; the disease is systemic lupus erythematosus.